Spero Therapeutics (SPRO) Short Interest
Nasdaq • SPRO • US84833T1034
As of Oct 27, 2026, ORTEX estimated 1.9% of free float sold short, 1.8 days to cover, cost to borrow 0.48%. Sign up for live short interest data.
Nasdaq • SPRO • US84833T1034
As of Oct 27, 2026, ORTEX estimated 1.9% of free float sold short, 1.8 days to cover, cost to borrow 0.48%. Sign up for live short interest data.
This page tracks how heavily Spero Therapeutics (Nasdaq:SPRO) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Spero Therapeutics (Nasdaq: SPRO) has a market capitalization of $59.4M. Last close $1.02 (as of 2026-11-12); 52-week range $0.96 to $3.08. ORTEX data as of 2026-10-27: short interest was 1.86% of free float, 1.8 days to cover and the average cost to borrow was 0.48%. Sign up for live short interest data.